Loading…
Community Pharmacy Fairness Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2008 · fourth_quarter · Labor Issues/Antitrust/Workplace
Issues related to antitrust exemptions for certain healthcare professional and labor organizing. HR 971, Community Pharmacy Fairness Act of 2007 S 885, Community Pharmacy Fairness Act of 2007 S 2161, Community Pharmacy Fairness Act of 2007 S 1041, Employee Free Choice Act of 2007 HR 800, Employee Free Choice Act of 2007
Client expense: $1,870,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
PHA (Pharmacy) (Legislative): H.R. 971: Community Pharmacy Fairness Act (Weiner); H.R. 1038: Access to Life-Saving Medicine Act (Waxman); H.R. 5629: Pathway for Biosimilars Act (Eshoo-Barton) (continued) PHA (Legislative) (continued): S. 316: Preserve Access to Affordable Generics Act (Kohl); S. 623: Access to Life-Saving Medicine Act (Schumer); S. 885: Community Pharmacy Fairness Act (Isakson); S. 1505: Affordable Biologics for Consumers Act (Gregg); S. 1695: Biologics Price Competition and Innovation Act (Kennedy) PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and issues related to electronic prescribing requirements; issues relating to e-prescribing of DEA controlled substances.
Client expense: $2,240,000 · Firm income: Not reported
2008 · fourth_quarter · Medicare/Medicaid
H.R.3162 - Children's Health and Medicare Protection Act of 2007, all titles H.R.3963 Childrens Health Insurance Program Reauthorization Act of 2007, all titles H.R.4 - Medicare Prescription Drug Negotiation Act of 2007, all titles H.R.6331 - Medicare Improvements for Patients and Providers Act of 2008, all titles H.R.971 - Community Pharmacy Fairness Act of 2007, all titles H.R.976 - Children's Health Insurance Program Reauthorization Act of 2007, all titles Implementation of Medicare Prescription Drug and Modernization Act of 2003 Implementation of Medicare, Medicaid, and SCHIP Extension Act of 2007 S.1695 - Biologics Price Competition and Innovation Act of 2007, all titles S.1893 - Children's Health Insurance Program Reauthorization Act of 2007, all titles S.1954 - Pharmacy Access Improvement (PhAIm) Act of 2007, all titles S.3101 - Medicare Improvements for Patients and Providers Act of 2008, all titles S.885 - Community Pharmacy Fairness Act of 2007, all titles
Client expense: Not reported · Firm income: $50,000
2008 · fourth_quarter · Health Issues
H.R.3162 - Children's Health and Medicare Protection Act of 2007, all titles H.R.3963 Childrens Health Insurance Program Reauthorization Act of 2007, all titles H.R.4 - Medicare Prescription Drug Negotiation Act of 2007, all titles H.R.6331 - Medicare Improvements for Patients and Providers Act of 2008, all titles H.R.971 - Community Pharmacy Fairness Act of 2007, all titles H.R.976 - Children's Health Insurance Program Reauthorization Act of 2007, all titles Implementation of Medicare Prescription Drug and Modernization Act of 2003 Implementation of Medicare, Medicaid, and SCHIP Extension Act of 2007 S.1695 - Biologics Price Competition and Innovation Act of 2007, all titles S.1893 - Children's Health Insurance Program Reauthorization Act of 2007, all titles S.1954 - Pharmacy Access Improvement (PhAIm) Act of 2007, all titles S.3101 - Medicare Improvements for Patients and Providers Act of 2008, all titles S.885 - Community Pharmacy Fairness Act of 2007, all titles
Client expense: Not reported · Firm income: $50,000
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · fourth_quarter · Labor Issues/Antitrust/Workplace
HR.971, Community Pharmacy Fairness Act of 2007 S.885, Community Pharmacy Fairness Act of 2007 S.2161, Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
Pharmacy issues - S 623, Access to Life-Saving Medicine Act; HR 1038, Access to Life-Saving Medicine Act; S 1505, Affordable Biologics for Consumers Act; S 316, Preserve Access to Affordable Generics Act; S 1695, Biologics Price Competition and Innovation Act of 2007; HR 971, Community Pharmacy Fairness Act of 2007; S 885, Community Pharmacy Fairness Act of 2007; HR 5629, Pathway for Biosimilars Act.
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Medicare/Medicaid
Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Competitive Acquuisition Program for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2008; all aspects
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
Health Information Technology, Electronic Prescribing, Comparative Effectiveness, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Carve-out of Generic Drugs from State Generic Substituion Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357- Protecting Records, Optimizing Treatment and Easing Communcations through Healthcare Technology PRO(TECH)T Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
Electronic Prescribing, Electronic Prescribing of Controlled Substances, Antitrust Exemption for Independent Pharmacies HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
See Addendum HR 971 and S 885 / S 2161- Community Pharmacy Fairness Act of 2007 HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007 HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 3140 - Saving Our Community Pharmacies Act of 2007 HR 3090 - Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 596 - Safe Internet Pharmacy Act of 2007 S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007 S 2161 - Community Pharmacy Fairness Act of 2007 S 877 - Controlling the Abuse of Prescription Act of 2007
Client expense: $314,868 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
2008 · fourth_quarter · Labor Issues/Antitrust/Workplace
HR 971 and S885 / S2161 - Community Pharmacy Fairness Act of 2007 Issues relating to the Department of Labor's proposed rule with regard to compensation disclosure for various service providers.
Client expense: $314,868 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
2008 · fourth_quarter · Pharmacy
Electronic Prescribing, Electronic Prescribing of Controlled Substances, Antitrust Exemption for Independent Pharmacies HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Health Issues
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Afforadable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S. 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S. 2990 - Medicare IVIG Acces Act of 2007; all aspects HR. 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357 - Protecting Records, Optimimizing Treatment and Easing Communications through Healthcare Technology (PRO[TECH]HIT) Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personlized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S 1814 - Health Information Privacy and Security Act; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Medicare/Medicaid
Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Medicare Demonstration Projects for Durable Medical Equipment HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicaer IVIG Access Act of 2008; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Pharmacy
H.R.5839, Safeguarding America's Pharmaceuticals Act S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: $205,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Labor Issues/Antitrust/Workplace
HR 971 and S885 / S2161 - Community Pharmacy Fairness Act of 2007 Issues relating to the Department of Labor's proposed rule with regard to compensation disclosure for various service providers.
Client expense: $324,944 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
2008 · third_quarter · Pharmacy
See Addendum HR 971 and S 885 / S 2161- Community Pharmacy Fairness Act of 2007 HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007 HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 3140 - Saving Our Community Pharmacies Act of 2007 HR 3090 - Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 596 - Safe Internet Pharmacy Act of 2007 S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007 S 2161 - Community Pharmacy Fairness Act of 2007 S 877 - Controlling the Abuse of Prescription Act of 2007
Client expense: $324,944 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
2008 · third_quarter · Pharmacy
Pharmacy issues - S 623, Access to Life-Saving Medicine Act; HR 1038, Access to Life-Saving Medicine Act; S 1505, Affordable Biologics for Consumers Act; S 316, Preserve Access to Affordable Generics Act; S 1695, Biologics Price Competition and Innovation Act of 2007; HR 971, Community Pharmacy Fairness Act of 2007; S 885, Community Pharmacy Fairness Act of 2007; HR 5629, Pathway for Biosimilars Act.
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2008 · third_quarter · Medicare/Medicaid
Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914/S.2990: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Medicare/Medicaid
Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914/S.2990: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Labor Issues/Antitrust/Workplace
Labor issues/Antitrust Issues/Workplace HR 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 S. 2161, Community Pharmacy Fairness Act of 2007
Client expense: $1,316,532 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Pharmacy
PHA (Pharmacy) (Legislative): H.R. 971: Community Pharmacy Fairness Act (Weiner); H.R. 1038: Access to Life-Saving Medicine Act (Waxman); H.R. 5629: Pathway for Biosimilars Act (Eshoo-Barton) (continued) PHA (Legislative) (continued): S. 316: Preserve Access to Affordable Generics Act (Kohl); S. 623: Access to Life-Saving Medicine Act (Schumer); S. 885: Community Pharmacy Fairness Act (Isakson); S. 1505: Affordable Biologics for Consumers Act (Gregg); S. 1695: Biologics Price Competition and Innovation Act (Kennedy) PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and issues related to electronic prescribing requirements; issues relating to e-prescribing of DEA controlled substances.
Client expense: $1,630,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of
2008 · third_quarter · Labor Issues/Antitrust/Workplace
HR.971, Community Pharmacy Fairness Act of 2007 S.885, Community Pharmacy Fairness Act of 2007 S.2161, Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 3610, Food and Drug Import Safety Act of 2007 H.R. 5619, Combat Methamphetamine Enhancement Act of 2008
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Medicare/Medicaid
H.R.3162 - Children's Health and Medicare Protection Act of 2007, all titles H.R.3963 Childrens Health Insurance Program Reauthorization Act of 2007, all titles H.R.4 - Medicare Prescription Drug Negotiation Act of 2007, all titles H.R.6331 - Medicare Improvements for Patients and Providers Act of 2008, all titles H.R.971 - Community Pharmacy Fairness Act of 2007, all titles H.R.976 - Children's Health Insurance Program Reauthorization Act of 2007, all titles Implementation of Medicare Prescription Drug and Modernization Act of 2003 Implementation of Medicare, Medicaid, and SCHIP Extension Act of 2007 S.1695 - Biologics Price Competition and Innovation Act of 2007, all titles S.1893 - Children's Health Insurance Program Reauthorization Act of 2007, all titles S.1954 - Pharmacy Access Improvement (PhAIm) Act of 2007, all titles S.3101 - Medicare Improvements for Patients and Providers Act of 2008, all titles S.885 - Community Pharmacy Fairness Act of 2007, all titles
Client expense: Not reported · Firm income: $50,000
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · third_quarter · Health Issues
H.R.3162 - Children's Health and Medicare Protection Act of 2007, all titles H.R.3963 Childrens Health Insurance Program Reauthorization Act of 2007, all titles H.R.4 - Medicare Prescription Drug Negotiation Act of 2007, all titles H.R.6331 - Medicare Improvements for Patients and Providers Act of 2008, all titles H.R.971 - Community Pharmacy Fairness Act of 2007, all titles H.R.976 - Children's Health Insurance Program Reauthorization Act of 2007, all titles Implementation of Medicare Prescription Drug and Modernization Act of 2003 Implementation of Medicare, Medicaid, and SCHIP Extension Act of 2007 S.1695 - Biologics Price Competition and Innovation Act of 2007, all titles S.1893 - Children's Health Insurance Program Reauthorization Act of 2007, all titles S.1954 - Pharmacy Access Improvement (PhAIm) Act of 2007, all titles S.3101 - Medicare Improvements for Patients and Providers Act of 2008, all titles S.885 - Community Pharmacy Fairness Act of 2007, all titles
Client expense: Not reported · Firm income: $50,000
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · third_quarter · Labor Issues/Antitrust/Workplace
Issues relating to the DOL's proposed disclosure of compensation for service fee providers under ERISA Providing an antitrust exemption for independent pharmacies (HR 971/S 885/S 2161)
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · third_quarter · Health Issues
Health Information Technology, Electronic Prescribing, Inappropriate use of Human Growth Hormone, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Carve-out of Generic Drugs from State Generic Substitution Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $434,097 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Pharmacy
Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $434,097 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Pharmacy
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all as
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
2008 · second_quarter · Pharmacy
PHA (Pharmacy) (Legislative): H.R. 971: Community Pharmacy Fairness Act (Weiner); H.R. 1038: Access to Life-Saving Medicine Act (Waxman); H.R. 5629: Pathway for Biosimilars Act (Eshoo-Barton) (continued) PHA (Legislative) (continued): S. 316: Preserve Access to Affordable Generics Act (Kohl); S. 623: Access to Life-Saving Medicine Act (Schumer); S. 885: Community Pharmacy Fairness Act (Isakson); S. 980: Online Pharmacy Consumer Protection Act (Feinstein); S. 1505: Affordable Biologics for Consumers Act (Gregg); S. 1695: Biologics Price Competition and Innovation Act (Kennedy) PHA (Regulatory): Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and issues related to electronic prescribing requirements.
Client expense: $1,850,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of
2008 · second_quarter · Labor Issues/Antitrust/Workplace
Labor issues/Antitrust Issues/Workplace HR 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 S. 2161, Community Pharmacy Fairness Act of 2007
Client expense: $1,010,101 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2008 · second_quarter · Health Issues
HR 971 and S 885 Community Pharmacy Fairness Act of 2007 HR 1474 Fair and Speedy Treatment of Medicare Prescription Drug Claims Act of 2007 HR 2970 Pharmacy Benefit Manager Transparency Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 S 242 Pharmaceutical Market Access and Drug Safety Act of 2007 S 251 Pharmaceutical Market Access Act of 2007 S 273 Prescription Drug and Health Improvement Act of 2007 S 1954 Pharmacy Access Improvement Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
HR 971 and S 885 Community Pharmacy Fairness Act of 2007 HR 1474 Fair and Speedy Treatment of Medicare Prescription Drug Claims Act of 2007 HR 2970 Pharmacy Benefit Manager Transparency Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 242 Pharmaceutical Maraket Access and Drug Safety Act of 2007 S 251 Pharmaceutical Market Access Act of 2007 S 1954 Pharmacy Access Improvement Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007
Client expense: $205,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · second_quarter · Labor Issues/Antitrust/Workplace
HR.971, Community Pharmacy Fairness Act of 2007 S.885, Community Pharmacy Fairness Act of 2007 S.2161, Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 H.R. 5839, Safeguarding America's Pharmaceuticals Act S. 207, Combat Methamphetamine Enhancement Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 H.R. 6353, Online Pharmacy Consumer Act S. 1954, Pharmacy Access Improvement Act of 2007
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · second_quarter · Pharmacy
Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $508,492 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
2008 · second_quarter · Health Issues
Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Medicare Part D Contract Disclsoure Requirements, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs, Over-the-Counter Drug Dispersement, Carve-out of Generic Drugs from State Medicaid Generic Substitution Laws HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2008; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $508,492 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
2008 · second_quarter · Pharmacy
Pharmacy issues - S 623, Access to Life-Saving Medicine Act; HR 1038, Access to Life-Saving Medicine Act; S 1505, Affordable Biologics for Consumers Act; S 316, Preserve Access to Affordable Generics Act; S 1695, Biologics Price Competition and Innovation Act of 2007; HR 971, Community Pharmacy Fairness Act of 2007; S 885, Community Pharmacy Fairness Act of 2007; S 980, Online Pharmacy Consumer Protection Act of 2007; HR 5629, Pathway for Biosimilars Act.
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2008 · second_quarter · Labor Issues/Antitrust/Workplace
providing an antitrust exemption for independent pharmacies (HR 971/S. 885/S 2161)
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
2008 · second_quarter · Medicare/Medicaid
Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Medicare/Medicaid
H.R.3162 - Children's Health and Medicare Protection Act of 2007, all titles H.R.3963 Childrens Health Insurance Program Reauthorization Act of 2007, all titles H.R.4 - Medicare Prescription Drug Negotiation Act of 2007, all titles H.R.6331 - Medicare Improvements for Patients and Providers Act of 2008, all titles H.R.971 - Community Pharmacy Fairness Act of 2007, all titles H.R.976 - Children's Health Insurance Program Reauthorization Act of 2007, all titles Implementation of Medicare Prescription Drug and Modernization Act of 2003 Implementation of Medicare, Medicaid, and SCHIP Extension Act of 2007 S.1695 - Biologics Price Competition and Innovation Act of 2007, all titles S.1893 - Children's Health Insurance Program Reauthorization Act of 2007, all titles S.1954 - Pharmacy Access Improvement (PhAIm) Act of 2007, all titles S.3101 - Medicare Improvements for Patients and Providers Act of 2008, all titles S.885 - Community Pharmacy Fairness Act of 2007, all titles
Client expense: Not reported · Firm income: $50,000
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · second_quarter · Health Issues
H.R.3162 - Children's Health and Medicare Protection Act of 2007, all titles H.R.3963 Childrens Health Insurance Program Reauthorization Act of 2007, all titles H.R.4 - Medicare Prescription Drug Negotiation Act of 2007, all titles H.R.6331 - Medicare Improvements for Patients and Providers Act of 2008, all titles H.R.971 - Community Pharmacy Fairness Act of 2007, all titles H.R.976 - Children's Health Insurance Program Reauthorization Act of 2007, all titles Implementation of Medicare Prescription Drug and Modernization Act of 2003 Implementation of Medicare, Medicaid, and SCHIP Extension Act of 2007 S.1695 - Biologics Price Competition and Innovation Act of 2007, all titles S.1893 - Children's Health Insurance Program Reauthorization Act of 2007, all titles S.1954 - Pharmacy Access Improvement (PhAIm) Act of 2007, all titles S.3101 - Medicare Improvements for Patients and Providers Act of 2008, all titles S.885 - Community Pharmacy Fairness Act of 2007, all titles
Client expense: Not reported · Firm income: $50,000
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
2008 · second_quarter · Health Issues
HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · second_quarter · Pharmacy
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · first_quarter · Health Issues
Health information technology, Electronic prescribing, Genetic Nondiscrimination, Inappropriate Use of Human Growth Hormone, Contract Disclosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-label Use of Prescription Drugs HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
Client expense: Not reported · Firm income: $60,000
2008 · first_quarter · Pharmacy
Electronic Prescribing, Pharmacy Payments, Pharmacy Antitrust Exemption, Internet Pharmacies. HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects ________
Client expense: Not reported · Firm income: $60,000